Stock Events

Stock Events

Lindbergh S.p.a. 

€8.3
0
+€0.1+1.22% Thursday 06:03

Statistics

Day High
8.3
Day Low
8.3
52W High
8.3
52W Low
3.22
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
349.31
Dividend Yield
-
Dividend
-

Earnings

11NovExpected
Q3 2024
Q1 2025
Q3 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

12.96%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
6.6BRevenue
854.92MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow D8M.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Lundbeck in the development and marketing of drugs for psychiatric and neurological disorders.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its Janssen Pharmaceuticals division, competes in the same therapeutic areas as Lundbeck, including mental health.
Novartis
NVS
Mkt Cap237.61B
Novartis offers products in neurology and psychiatry, directly competing with Lundbeck's portfolio.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly has a strong presence in the psychiatric medication market, making it a direct competitor to Lundbeck.
Merck
MRK
Mkt Cap214.76B
Merck & Co. competes with Lundbeck in the area of brain health, including treatments for neurological conditions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries has a broad portfolio that includes CNS (central nervous system) drugs, competing with Lundbeck.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, with its neuroscience division, offers products that compete in the same space as Lundbeck's treatments.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb has a range of psychiatric and neurological drugs, positioning it as a competitor to Lundbeck.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca operates in various therapeutic areas, including those that overlap with Lundbeck's CNS focus.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline has a diversified portfolio that includes medications for mental health, competing with Lundbeck.

About

Lindbergh S.p.A. provides maintains, repairs, and logistics solutions in Italy. The company offers spare parts delivery, return management system, personal protective equipment supply, tool testing, waste disposal, customized/on demand; and work clothing and accessories services. Lindbergh S.p.A. was founded in 2006 and is based in Pescarolo ed Uniti, Italy.
Show more...
CEO
Employees
1001
Country
IT
ISIN
IT0005469272
WKN
000A3C9MS

Listings

F
DE
D8M.F
Grey Market
US
LDBMF
OTC Link
US
HLBBF
LSE
GB
0ABR.LSE

0 Comments

Share your thoughts

FAQ

What is Lindbergh S.p.a. stock price today?▼
The current price of D8M.F is €8.3 EUR — it has increased by +1.22% in the past 24 hours. Watch Lindbergh S.p.a. stock price performance more closely on the chart.
What is Lindbergh S.p.a. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lindbergh S.p.a. stocks are traded under the ticker D8M.F.
Is Lindbergh S.p.a. stock price growing?▼
D8M.F stock has risen by +6.14% compared to the previous week, the month change is a +5.06% rise, over the last year Lindbergh S.p.a. has showed a +137.14% increase.
What is Lindbergh S.p.a. revenue for the last year?▼
Lindbergh S.p.a. revenue for the last year amounts to 6.6B EUR.
What is Lindbergh S.p.a. net income for the last year?▼
D8M.F net income for the last year is 854.92M EUR.
How many employees does Lindbergh S.p.a. have?▼
As of April 03, 2026, the company has 1,001 employees.
In which sector is Lindbergh S.p.a. located?▼
Lindbergh S.p.a. operates in the Materials sector.
When did Lindbergh S.p.a. complete a stock split?▼
Lindbergh S.p.a. has not had any recent stock splits.